Why the J&J Covid Vaccine Could Protect Millions
Bloomberg Businessweek

Why the J&J Covid Vaccine Could Protect Millions

Mar 2, 2021
35:05
-(0)

About this episode

Bloomberg News Health Care Reporter Angelica LaVito discusses why the J&J Covid vaccine could protect millions -- if they take it. Bloomberg Businessweek Editor Joel Weber and Businessweek Freelance Writer Josh Hunt talk about a Nike executive leaving following a report about her son’s business. Bloomberg News Wealth Reporter Anders Melin and Bloomberg News Finance Reporter Sri Natarajan shares insight on Goldman’s chief lawyer departing as senior exits grow at the bank. And we Drive to the Close with Ron Carson, CEO of Carson Group. Hosts: Carol Massar and Tim Stenovec. Producer: Doni Holloway. See omnystudio.com/listener for privacy information.

Comments

Rate this episode

Episode Details

Author
Bloomberg
Show Type
full
Audio Format
audio/mpeg

We use analytics

We use Umami, a privacy-friendly analytics tool, to understand how visitors use this site. No personal data is collected and no data leaves our EU servers. You can accept or decline below. Privacy Policy